# ADHD

- Risk factors. Increased prevalence of ADHD exist in the following:
  - C&A: OOHC, ODD, CD, anxiety disorders, epilepsy, substance abuse
  - Adults: any mental health disorder, with suicidal behaviour or ideation
  - Neurodevelopmental disorders
  - Family history of ADHD
  - Developmental injury: preterm, prenatal exposure to substances, ABI
- Screening
  - Should not be performed universally, however is recommended in people with risk-factors
- Diagnosis
  - Full clinical and psychosocial assessment
    - Symptoms
    - Manifestations
    - Impairments
  - Developmental, PMHx and past psychiatric Hx
  - Collateral
  - Exclusion of differentials

## General including Child & Adolescent

### Management

- Non-pharmacological
  - In summary, live a good life + psychotherapy + ADHD coaching + neurofeedback
  - The evidence to support these are minimal, however risk/benefit analysis remains favourable
  - Lifestyle: essentially sleep hygeine practices
    - Optimise diet
    - Optimise sleep
    - Optimise exercise
    - Avoid substance use including alcohol and smoking
  - Psychotherapy
    - **Psychoeducation**
    - Cognitive behavioural therapy
    - Mindfulness-based cognitive therapy
    - Dialectical behavioural therapy
    - Parent-family training: techniques to support parenting children with ADHD
  - Social
    - ADHD lifestyle coaching
    - Alarms, reminders
    - Neurofeedback
- Pharmacological

## Adult Specific

- Assessment
  - Psychometrics
    - Diagnostic Interview for Adult ADHD (DIVA-5)
  - 
- Management
  - First-line: methylphenidate or lisdexamfetamine
    - Trial for 6 weeks
  - If responding to lisdexamfetamine but unable to be tolerated: switch to dexamfetamine
  - If first-lines unable to be tolerated, offer atomoxetine
- Short-acting vs long-acting
  - 

## References
- https://adhdguideline.aadpa.com.au/wp-content/uploads/2022/10/ADHD-Clinical-Practice-Guide-Summary-of-Recommendations-031022.pdf
- https://adhdguideline.aadpa.com.au/wp-content/uploads/2024/06/Australian-Clinical-Practice-Guideline-For-ADHD-June-2024.pdf